[1]
Ahmed, H., Abushouk, A.I., Gadelkarim, M., Mohamed, A., Gabr, M. and Negida, A. 2017. Efficacy of daclatasvir plus peginterferon alfa and ribavirin for patients with chronic hepatitis C genotype 4 infection. Bangladesh Journal of Pharmacology. 12, 1 (Mar. 2017), 12–22. DOI:https://doi.org/10.3329/bjp.v12i1.29940.